Browsing Tag
Decnupaz
1 post
AbbVie (ABBV) raises 2026 revenue guidance as Skyrizi and Rinvoq lift Q2 revenue to $17bn
AbbVie posted Q2 2026 revenue of $16.99 billion as Skyrizi crossed $5.5bn quarterly, but the pending $10.9bn Apogee deal trimmed 2026 adjusted EPS guidance.